Ropes & Gray Advises Alexion's $855M Swedish Drug Co. Buy
Ropes & Gray LLP is advising Alexion Pharmaceuticals Inc. in its proposed $855 million acquisition of Wilson Therapeutics, a Swedish developer of therapies for patients with rare copper-mediated disorders that's being...To view the full article, register now.
Already a subscriber? Click here to view full article